Genome-wide methylation profiling of ovarian cancer patient-derived xenografts treated with the demethylating agent decitabine identifies novel epigenetically regulated genes and pathways.

Saved in:
Bibliographic Details
Title: Genome-wide methylation profiling of ovarian cancer patient-derived xenografts treated with the demethylating agent decitabine identifies novel epigenetically regulated genes and pathways.
Authors: Tomar, Tushar1, de Jong, Steven2, Alkema, Nicolette G.1, Hoekman, Rieks L.1, Jan Meersma, Gert1, Kilp, Harry G.1, der Zee, Ate GJ van1, Wisman, G. Bea A.1 g.b.a.wisman@umcg.nl
Source: Genome Medicine. 10/20/2016, Vol. 8, p1-15. 15p.
Database: Academic Search Ultimate
Description
ISSN:1756994X
DOI:10.1186/s13073-016-0361-5